COVID-19肺炎与其他类型病毒性肺炎胸部CT表现比较:一项两中心回顾性研究
该两中心回顾性研究比较了154例RT-PCR确诊的COVID-19肺炎与100例其他类型病毒性肺炎的胸部HRCT表现。多因素logistic回归显示,外周分布、病灶最大范围>10 cm、累及5个肺叶、存在肺门及纵隔淋巴结增大、无胸腔积液与COVID-19肺炎显著相关。
要点
- 外周分布、病灶最大范围>10 cm、累及5个肺叶、肺门及纵隔淋巴结增大、无胸腔积液与COVID-19肺炎显著相关。
- 外周分布较弥漫分布的COVID-19肺炎风险比为13.04倍。
- 病灶最大范围>10 cm较≤5 cm的COVID-19肺炎风险比为9.75倍。
关键影像表现/征象
- 外周分布与COVID-19肺炎相关,较弥漫分布的风险比为13.04倍。
- 病灶最大范围>10 cm与COVID-19肺炎相关,较最大范围≤5 cm的风险比为9.75倍。
- 累及5个肺叶与COVID-19肺炎相关,原文表述为较最大范围≤2的风险比为8.45倍,原文此处写作「最大范围≤2」,按上下文应为肺叶受累数。
- 无胸腔积液与COVID-19肺炎相关,较有胸腔积液的风险比为3.58倍。
- 存在肺门及纵隔淋巴结增大与COVID-19肺炎相关,风险比为2.79倍。
诊断标准与关键数值
- 外周分布较弥漫分布与COVID-19肺炎相关的风险比为13.04倍。
- 病灶最大范围>10 cm较≤5 cm与COVID-19肺炎相关的风险比为9.75倍。
- 累及5个肺叶与COVID-19肺炎相关的风险比为8.45倍,原文表述为较最大范围≤2,原文此处表述有矛盾。
- 无胸腔积液较有胸腔积液与COVID-19肺炎相关的风险比为3.58倍。
- 存在肺门及纵隔淋巴结增大与COVID-19肺炎相关的风险比为2.79倍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare the pulmonary chest CT findings of patients with COVID-19 pneumonia with those with other types of viral pneumonia.
METHODS: This retrospective review includes 154 patients with RT-PCR-confirmed COVID-19 pneumonia diagnosed between February 11 and 20, 2020, and 100 patients with other types of viral pneumonia diagnosed between April 2011 and December 2020 from two hospitals. High-resolution CT (HRCT) of the chest was performed. Data on location, distribution, attenuation, maximum lesion range, lobe involvement, number of lesions, air bronchogram signs, Hilar and mediastinal lymph node enlargement, and pleural effusion were collected. Associations between imaging characteristics and COVID-19 pneumonia were analyzed with univariate and multivariate logistic regression models.
RESULTS: A peripheral distribution was associated with a 13.04-fold risk of COVID-19 pneumonia, compared with a diffuse distribution. A maximum lesion range > 10 cm was associated with a 9.75-fold risk of COVID-19 pneumonia, compared with a maximum lesion range ≤ 5 cm, and the involvement of 5 lobes was associated with an 8.45-fold risk of COVID-19 pneumonia, compared with a maximum lesion range ≤ 2. No pleural effusion was associated with a 3.58-fold risk of COVID-19 pneumonia compared with the presence of pleural effusion. Hilar and mediastinal lymph node enlargement was associated with a 2.79-fold risk of COVID-19 pneumonia.
CONCLUSION: A peripheral distribution, a lesion range > 10 cm, involvement of 5 lobes, presence of hilar and mediastinal lymph node enlargement, and no pleural effusion were significantly associated with 2019-novel coronavirus pneumonia.
KEY POINTS: • A peripheral distribution, a lesion range > 10 cm, involvement of 5 lobes, presence of hilar and mediastinal lymph node enlargement, and no pleural effusion were significantly associated with COVID-19 compared with other types of viral pneumonia.
引用
- Li X, Fang X, Bian Y, et al. Comparison of chest CT findings between COVID-19 pneumonia and other types of viral pneumonia: a two-center retrospective study. Eur Radiol. 2020. PMID: 32394279. doi:10.1007/s00330-020-06925-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。